EUVIMEDEUVIMED entdecken
Crossref

EZH2 Expression Is Associated With Sensitivity to Inhibitors and Promotes Malignancy in Endometrial Cancer Cells

Takafumi Onishi, Hiroya Niimi, Aya Kumazaki, Yuto Masaki, Shoma Nomura, Hirokazu Odashima, Yukihiko Osawa, Manabu Hattori

Anticancer Research · 2026

DOI: 10.21873/anticanres.18027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Takafumi Onishi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Technology and Sciences, Faculty of Health Sciences, Kyoto Tachibana University, Kyoto, Japan; onishi-ta@tachibana-u.ac.jp. Hauptthemen laut MEDLINE: Enhancer of Zeste Homolog 2 Protein, Endometrial Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enhancer of Zeste Homolog 2 ProteinEndometrial NeoplasmsAntineoplastic AgentsHumansFemaleCell Line, TumorCell ProliferationCell MovementGene Expression Regulation, NeoplasticDrug Resistance, NeoplasmPyridones

Stichwörter der Autor:innen

Endometrial cancerdrug sensitivityenhancer of zeste homolog 2knockdowntumor inhibition

Substanzen

Enhancer of Zeste Homolog 2 ProteinEZH2 protein, humanPyridonesAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Medical Technology and Sciences, Faculty of Health Sciences, Kyoto Tachibana University, Kyoto, Japan; onishi-ta@tachibana-u.ac.jp.
  • Research Center for Life and Health Sciences, Kyoto Tachibana University, Kyoto, Japan.
  • Graduate School of Health Sciences, Department of Health Sciences, Kyoto Tachibana University, Kyoto, Japan.
  • Department of Pathology, Aichi Medical University Hospital, Aichi, Japan.
  • Department of Pathology, Otsu City Hospital, Shiga, Japan.
  • Department of Medical Technology and Sciences, Faculty of Health Sciences, Kyoto Tachibana University, Kyoto, Japan.

Zitieren

APA

Onishi, T., Niimi, H., Kumazaki, A., Masaki, Y., Nomura, S., Odashima, H., Osawa, Y., & Hattori, M. (2026). EZH2 Expression Is Associated With Sensitivity to Inhibitors and Promotes Malignancy in Endometrial Cancer Cells. Anticancer Research. https://doi.org/10.21873/anticanres.18027

Vancouver

Onishi T, Niimi H, Kumazaki A, Masaki Y, Nomura S, Odashima H, et al. EZH2 Expression Is Associated With Sensitivity to Inhibitors and Promotes Malignancy in Endometrial Cancer Cells. Anticancer Research. 2026. doi:10.21873/anticanres.18027

BibTeX
@article{Onishi2026,
  author = {Onishi, Takafumi and Niimi, Hiroya and Kumazaki, Aya and Masaki, Yuto and Nomura, Shoma and Odashima, Hirokazu and Osawa, Yukihiko and Hattori, Manabu},
  title = {EZH2 Expression Is Associated With Sensitivity to Inhibitors and Promotes Malignancy in Endometrial Cancer Cells},
  journal = {Anticancer Research},
  year = {2026},
  doi = {10.21873/anticanres.18027}
}
Kostenlos starten →